Gesamtpublikationsliste

2013

107.
A. Li, R. Hardy, S. Stoner, J. P. Tuckermann, M. Seibel and H. Zhou, "Deletion of mesenchymal glucocorticoid receptor attenuates embryonic lung development and abdominal wall closure" , PLoS ONE, vol. 8, no. 5, pp. e63578, Mai 2013.
106.
C. Scholtysek, J. Katzenbeisser, H. Fu, S. Uderhardt, N. Ipseiz, C. Stoll, M. M. Zaiss, M. Stock, L. Donhauser, C. Böhm, A. Kleyer, A. Hess, K. Engelke, J. P. David, F. Djouad, J. P. Tuckermann, B. Desvergne, G. Schett and G. Krönke, "PPAR'ce'b2/'ce'b4 governs Wnt signaling and bone turnover" , Nat. Med., vol. 19, no. 5, pp. 608-613, Mai 2013.
105.
T. Zee, S. Boller, I. Gyory, M. P. Makinistoglu, J. P. Tuckermann, R. Grosschedl and G. Karsenty, "The transcription factor early B-cell factor 1 regulates bone formation in an osteoblast-nonautonomous manner" , FEBS Lett., vol. 587, no. 6, pp. 711-716, Mä. 2013.
104.
S. Vandevyver, L. Dejager, J. P. Tuckermann and C. Libert, "New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation" , Endocrinology, vol. 154, no. 3, pp. 993-1007, Mä. 2013.
103.
G. Casanovas, M. Vujić Spasić, C. Casu, S. Rivella, J. Strelau, K. Unsicker and M. U. Muckenthaler, "The murine growth differentiation factor 15 is not essential for systemic iron homeostasis in phlebotomized mice" , Haematologica, vol. 98, no. 3, pp. 444-447, Mä. 2013.
102.
M. Vujić Spasić, R. Sparla, K. Mleczko-Sanecka, M. C. Migas, K. Breitkopf-Heinlein, S. Dooley, S. Vaulont, R. E. Fleming and M. U. Muckenthaler, "Smad6 and Smad7 are co-regulated with hepcidin in mouse models of iron overload" , Biochim. Biophys. Acta, vol. 1832, no. 1, pp. 76-84, Jan. 2013.
101.
I. C. Cirstea, L. Gremer, R. Dvorsky, S. C. Zhang, R. P. Piekorz, M. Zenker and M. R. Ahmadian, "Diverging gain-of-function mechanisms of two novel KRAS mutations associated with Noonan and cardio-facio-cutaneous syndromes" , Hum. Mol. Genet., vol. 22, no. 2, pp. 262-270, 2013.

2012

100.
A. Kleyer, C. Scholtysek, E. Bottesch, U. Hillienhof, C. Beyer, J. H. Distler, J. P. Tuckermann, G. Schett and G. Krönke, "Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss" , J. Bone Miner. Res., vol. 27, no. 12, pp. 2442-2451, Dez. 2012.
99.
U. Baschant, N. E. Lane and J. P. Tuckermann, "The multiple facets of glucocorticoid action in rheumatoid arthritis" , Nat Rev Rheumatol, vol. 8, no. 11, pp. 645-655, Nov. 2012.
98.
S. Thiele, N. Ziegler, E. Tsourdi, K. De Bosscher, J. P. Tuckermann, L. C. Hofbauer and M. Rauner, "Selective glucocorticoid receptor modulation maintains bone mineral density in mice" , J. Bone Miner. Res., vol. 27, no. 11, pp. 2242-2250, Nov. 2012.
97.
K. M. Mueller, M. Themanns, K. Friedbichler, J. W. Kornfeld, H. Esterbauer, J. P. Tuckermann and R. Moriggl, "Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development" , Mol. Cell. Endocrinol., vol. 361, no. 1-2, pp. 1-11, Sep. 2012.
96.
A. Illing, P. Liu, S. Ostermay, A. Schilling, G. de Haan, A. Krust, M. Amling, P. Chambon, T. Schinke and J. P. Tuckermann, "Estradiol increases hematopoietic stem and progenitor cells independent of its actions on bone" , Haematologica, vol. 97, no. 8, pp. 1131-1135, Aug. 2012.
95.
L. Gutierrez, M. Vujić Spasić, M. U. Muckenthaler and F. J. Lazaro, "Quantitative magnetic analysis reveals ferritin-like iron as the most predominant iron-containing species in the murine Hfe-haemochromatosis" , Biochim. Biophys. Acta, vol. 1822, no. 7, pp. 1147-1153, Jul. 2012.
94.
K. Benesova, M. Vujić Spasić, S. M. Schaefer, J. Stolte, T. Baehr-Ivacevic, K. Waldow, Z. Zhou, U. Klingmueller, V. Benes, M. A. Mall and M. U. Muckenthaler, "Hfe deficiency impairs pulmonary neutrophil recruitment in response to inflammation" , PLoS ONE, vol. 7, no. 6, pp. e39363, Jun. 2012.
93.
S. Vandevyver, L. Dejager, T. Van Bogaert, A. Kleyman, Y. Liu, J. P. Tuckermann and C. Libert, "Glucocorticoid receptor dimerization induces MKP1 to protect against TNF-induced inflammation" , J. Clin. Invest., vol. 122, no. 6, pp. 2130-2140, Jun. 2012.
92.
S. Hübner and J. P. Tuckermann, "Molecular mechanisms of the glucocorticoid receptor in steroid therapy - lessons from transgenic mice" , Biomol Concepts, vol. 3, no. 3, pp. 241-253, Jun. 2012.
91.
C. Böhm, A. Derer, R. Axmann, U. Hillienhof, M. M. Zaiss, J. Luther, C. Zech, M. Stock, C. Scholtysek, K. Engelke, A. Hess, J. P. Tuckermann, G. Schett and J. P. David, "RSK2 protects mice against TNF-induced bone loss" , J. Cell. Sci., vol. 125, no. Pt 9, pp. 2160-2171, Mai 2012.
90.
M. L. Watson, L. M. Baehr, H. M. Reichardt, J. P. Tuckermann, S. C. Bodine and J. D. Furlow, "A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure" , Am. J. Physiol. Endocrinol. Metab., vol. 302, no. 10, pp. E1210-1220, Mai 2012.
89.
S. D. Reichardt, M. Foller, R. Rexhepaj, G. Pathare, K. Minnich, J. P. Tuckermann, F. Lang and H. M. Reichardt, "Glucocorticoids enhance intestinal glucose uptake via the dimerized glucocorticoid receptor in enterocytes" , Endocrinology, vol. 153, no. 4, pp. 1783-1794, Apr. 2012.
88.
T. Röszer and G. Banfalvi, "FMRFamide-related peptides: anti-opiate transmitters acting in apoptosis" , Peptides, vol. 34, no. 1, pp. 177-185, Mä. 2012.
87.
A. Kleiman, S. Hübner, J. M. Rodriguez Parkitna, A. Neumann, S. Hofer, M. A. Weigand, M. Bauer, W. Schmid, G. Schutz, C. Libert, H. M. Reichardt and J. P. Tuckermann, "Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages" , FASEB J., vol. 26, no. 2, pp. 722-729, Feb. 2012.
86.
T. Röszer, The Biology of Subcellular Nitric Oxide. .... Springer Netherlands, 2012.
ISBN:978-94-007-2819-6
85.
M. P. Menendez-Gutierrez, T. Röszer and M. Ricote, "Biology and therapeutic applications of peroxisome proliferator- activated receptors" , Curr Top Med Chem, vol. 12, no. 6, pp. 548-584, 2012.
84.
Z. Stark, G. Gillessen-Kaesbach, M. M. Ryan, I. C. Cirstea, L. Gremer, M. R. Ahmadian, R. Savarirayan and M. Zenker, "Two novel germline KRAS mutations: expanding the molecular and clinical phenotype" , Clin. Genet., vol. 81, no. 6, pp. 590-594, 2012.
83.
S. Seitz, J. Keller, A. F. Schilling, A. Jeschke, R. P. Marshall, B. D. Stride, T. Wintermantel, F. T. Beil, M. Amling, G. Schutz, J. P. Tuckermann and T. Schinke, "Pharmacological estrogen administration causes a FSH-independent osteo-anabolic effect requiring ER alpha in osteoblasts" , PLoS ONE, vol. 7, no. 11, pp. e50301, 2012.